Data / Form D filings / Chrysalis Biotherapeutics, Inc.
Chrysalis Biotherapeutics, Inc.: Form D filing
Chrysalis Biotherapeutics, Inc., a pharmaceuticals company in Galveston, TX, filed a Form D with the SEC in 2024. The latest, on March 22, 2024, reports $515,000 sold of a $3 million offering to 12 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2200 MARKET ST, SUITE 606, Galveston, TX, 77550
- Phone
- (409) 497-4038
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2016438
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 22, 2024 | New notice | $3,000,000 | $515,000 | $2,485,000 | 12 | Nov 28, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Lauri Sower | Executive Officer | |
| Darrell Carney | Executive Officer, Director | |
| Timothy Schmidt | Director | |
| James Ryaby | Director | |
| Marie Robb | Director | |
| Jeffery Sheldon | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
- InnovoTEX Inc. $749,951 · Aug 6, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Chrysalis Biotherapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.